The importance of GLP-1 therapies for type 2 diabetes and CVD Today it is well established that excessive body fat together with lack of regular physical activity, together with a genetic predisposition, are the main causes of type 2 diabetes, contributing as well to a substantial proportion of cardiovascular diseases, cancers, and other chronic degenerative diseases
By the time you have showered, dressed, and prepared for the day, the 30 minutes have passed and coffee is ready
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Subcutaneous injections resolved the oral bioavailability issues of incretins while the short half-life barrier was resolved when researchers identified other animals that also produce similar GLP-1 molecules [25]
